載入...
Niclosamide inhibits the cell proliferation and enhances the responsiveness of esophageal cancer cells to chemotherapeutic agents
Niclosamide is an FDA-approved anthelmintic drug, and may elicit antineoplastic effects through direct STAT3 inhibition, which has been revealed in numerous human cancer cells. Chemotherapy is the standard treatment for advanced esophageal cancers, but also causes severe systemic side effects. The p...
Na minha lista:
| 發表在: | Oncol Rep |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6967135/ https://ncbi.nlm.nih.gov/pubmed/31894334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7449 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|